ACAAI 2021

Conference Coverage

CHRONICLE Trial Identifies Exacerbation Triggers of Severe Asthma

Dupilumab Improves Chronic Rhinosinusitis With Nasal Polyps, Comorbid Asthma

Initiate Biologic Therapy Sooner in Uncontrolled Severe Asthma?

Can a Patient’s Asthma Impairment and Risk Questionnaire Score Predict HRQoL?

Lebrikizumab May Improve Lung Function in Severe Eosinophilic Asthma

Can Biologics Cut Steroid Exposure in Aspirin-Exacerbated Respiratory Disease?

Dupilumab Improves Chances of Clinical Remission in Uncontrolled Asthma

The Effects of Rhinovirus in Children With Severe Wheeze

Benralizumab Reduces Asthma Exacerbations, ED Visits, and Hospitalizations

Allergen Immunotherapy for Allergic Rhinitis Has Favorable Real-World Outcomes

Does Biologics’ Efficacy in Asthma Always Vary With Blood Eosinophil Counts?

Obesity, Dysanapsis, and Peripheral Airway Impairment in Children With Asthma

Managing Patients With COVID-19 and Common Variable Immunodeficiency

Latino Patients With Asthma Have Longer Exacerbations Post-COVID-19

REALISE Trial: Safety of Viaskin Peanut Patch in Children With Peanut Allergies

Does Doxycycline Therapy in COVID-19 Pneumonia Improve Mortality?

VESTIGE Asthma Trial Uses Functional Respiratory Imaging to Assess Dupilumab

Cannabis Knowledge, Attitudes, and Practice Among Allergists